Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EPS Creative Health Technology Group Limited ( (HK:3860) ) has issued an announcement.
EPS Creative Health Technology Group Limited has scheduled a board meeting on November 27, 2025, to review and approve the company’s unaudited interim results for the six months ending September 30, 2025, and to consider the payment of an interim dividend. This meeting could have significant implications for the company’s financial performance and shareholder returns, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (HK:3860) stock is a Buy with a HK$1.00 price target. To see the full list of analyst forecasts on EPS Creative Health Technology Group Limited stock, see the HK:3860 Stock Forecast page.
More about EPS Creative Health Technology Group Limited
EPS Creative Health Technology Group Limited operates in the health technology industry, focusing on innovative health solutions and services.
Average Trading Volume: 194,502
Technical Sentiment Signal: Buy
Current Market Cap: HK$391.6M
For a thorough assessment of 3860 stock, go to TipRanks’ Stock Analysis page.

